Table 1.

HIV-1 and EBV epitopic peptides used

HLAVirusPeptideHLAVirusPeptide
A1HIVNef 121–128A31HIVEnv 775–785
HIVNef 184–191HIVGag 20–28
A2EBVLMP-2 426–434HIVGag 83–91
HIVEnv 37–46HIVNef 84–92
HIVEnv 121–129A32HIVEnv 424–432
HIVGag 77–85HIVEnv 774–782
HIVPol 200–208HIVPol 589–568
HIVPol 476–484B7EBVEBNA-3A 379–387
HIVPol 588–596EBVEBNA-3C 881–891
HIVPol 683–692HIVEnv 303–312
HIVNef 136–145HIVEnv 848–856
A3HIVEnv 775–785HIVNef 68–77
HIVGag 18–26HIVNef 128–137
HIVGag 20–28B8EBVEBNA-3 325–33
HIVGag 266–275HIVEnv 591–598
HIVPol 325–333HIVEnv 851–859
HIVNef 73–82HIVGag 24–32
A11EBVEBNA-4 416–424HIVGag 259–267
HIVGag 83–91HIVGag 329–337
HIVGag 349–359HIVPol 185–193
HIVPol 325–333HIVNef 90–97
HIVPol 507–517B27HIVEnv 791–800
HIVNef 73–82HIVGag 263–272
HIVNef 84–92HIVNef 134–141
A24HIVEnv 590–598B35EBVEBNA-3 458–466
HIVPol 508–517HIVGag 254–262
HIVNef 134–143HIVPol 342–350
A25HIVNef 135–143HIVNef 68–77
A30EBVEBNA-3A 603–611HIVNef 74–81
HIVGag 20–28HIVNef 135–143
HIVNef 73–82B44EBVEBNA-3C 163–171
EBVEBNA-6 290–299
HIVGag 178–186